| Pruitthealth Hospice-swainsboro 667 S Main Street, Swainsboro, GA, 30401 | |
| (478) 237-7798 |
News Archive
As the cost of sequencing a single human genome drops rapidly, with one company predicting a price of $100 per person in five years, soon the only reason not to look at your "personal genome" will be fear of what bad news lies in your genes.
Nanoparticles are everywhere. From cosmetics and clothes, to soda and snacks. But as versatile as they are, nanoparticles also have a downside, say researchers at Binghamton University and Cornell University in a recent paper published in the journal Nature Nanotechnology. These tiny particles, even in low doses, could have a big impact on our long-term health.
Annually changing flu vaccines with their hit-and-miss effectiveness may soon give way to a single, near-universal flu vaccine, according to a new report from scientists at The Scripps Research Institute and the Dutch biopharmaceutical company Crucell. They describe an antibody that, in animal tests, can prevent or cure infections with a broad variety of influenza viruses, including seasonal and potentially pandemic strains.
CRISPR, a system of genes that bacteria use to defend themselves against viruses, has been found to be involved in helping some bacteria evade the mammalian immune system.
The Vasculitis Patient-Powered Research Network, led by Peter A. Merkel, MD, MPH, Professor of Medicine and Epidemiology at the University of Pennsylvania and George Casey, MBA, Vice President of the Vasculitis Foundation, has been approved to receive a three-year $1.4 million award by the Patient-Centered Outcomes Research Institute as part of the second phase of the National Patient-Centered Clinical Research Network.
› Verified 1 days ago
| Name | Pruitthealth Hospice-swainsboro |
|---|---|
| Location | 667 S Main Street, Swainsboro, Georgia |
| Hospice ID | 111572 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 440 |
News Archive
As the cost of sequencing a single human genome drops rapidly, with one company predicting a price of $100 per person in five years, soon the only reason not to look at your "personal genome" will be fear of what bad news lies in your genes.
Nanoparticles are everywhere. From cosmetics and clothes, to soda and snacks. But as versatile as they are, nanoparticles also have a downside, say researchers at Binghamton University and Cornell University in a recent paper published in the journal Nature Nanotechnology. These tiny particles, even in low doses, could have a big impact on our long-term health.
Annually changing flu vaccines with their hit-and-miss effectiveness may soon give way to a single, near-universal flu vaccine, according to a new report from scientists at The Scripps Research Institute and the Dutch biopharmaceutical company Crucell. They describe an antibody that, in animal tests, can prevent or cure infections with a broad variety of influenza viruses, including seasonal and potentially pandemic strains.
CRISPR, a system of genes that bacteria use to defend themselves against viruses, has been found to be involved in helping some bacteria evade the mammalian immune system.
The Vasculitis Patient-Powered Research Network, led by Peter A. Merkel, MD, MPH, Professor of Medicine and Epidemiology at the University of Pennsylvania and George Casey, MBA, Vice President of the Vasculitis Foundation, has been approved to receive a three-year $1.4 million award by the Patient-Centered Outcomes Research Institute as part of the second phase of the National Patient-Centered Clinical Research Network.
› Verified 1 days ago
| NPI Number | 1013955749 |
| Organization Name | Pruitthealth Hospice, Inc |
| Address | 667 South Main Street Swainsboro, Georgia, 30401 |
| Phone Number | (478)237-7798 |
News Archive
As the cost of sequencing a single human genome drops rapidly, with one company predicting a price of $100 per person in five years, soon the only reason not to look at your "personal genome" will be fear of what bad news lies in your genes.
Nanoparticles are everywhere. From cosmetics and clothes, to soda and snacks. But as versatile as they are, nanoparticles also have a downside, say researchers at Binghamton University and Cornell University in a recent paper published in the journal Nature Nanotechnology. These tiny particles, even in low doses, could have a big impact on our long-term health.
Annually changing flu vaccines with their hit-and-miss effectiveness may soon give way to a single, near-universal flu vaccine, according to a new report from scientists at The Scripps Research Institute and the Dutch biopharmaceutical company Crucell. They describe an antibody that, in animal tests, can prevent or cure infections with a broad variety of influenza viruses, including seasonal and potentially pandemic strains.
CRISPR, a system of genes that bacteria use to defend themselves against viruses, has been found to be involved in helping some bacteria evade the mammalian immune system.
The Vasculitis Patient-Powered Research Network, led by Peter A. Merkel, MD, MPH, Professor of Medicine and Epidemiology at the University of Pennsylvania and George Casey, MBA, Vice President of the Vasculitis Foundation, has been approved to receive a three-year $1.4 million award by the Patient-Centered Outcomes Research Institute as part of the second phase of the National Patient-Centered Clinical Research Network.
› Verified 1 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.7 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 98.0 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 97.3 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 85.4 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.7 | 97.3 |
| Patients who got timely treatment for shortness of breath | 95.7 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 96.4 | 93.3 |
News Archive
As the cost of sequencing a single human genome drops rapidly, with one company predicting a price of $100 per person in five years, soon the only reason not to look at your "personal genome" will be fear of what bad news lies in your genes.
Nanoparticles are everywhere. From cosmetics and clothes, to soda and snacks. But as versatile as they are, nanoparticles also have a downside, say researchers at Binghamton University and Cornell University in a recent paper published in the journal Nature Nanotechnology. These tiny particles, even in low doses, could have a big impact on our long-term health.
Annually changing flu vaccines with their hit-and-miss effectiveness may soon give way to a single, near-universal flu vaccine, according to a new report from scientists at The Scripps Research Institute and the Dutch biopharmaceutical company Crucell. They describe an antibody that, in animal tests, can prevent or cure infections with a broad variety of influenza viruses, including seasonal and potentially pandemic strains.
CRISPR, a system of genes that bacteria use to defend themselves against viruses, has been found to be involved in helping some bacteria evade the mammalian immune system.
The Vasculitis Patient-Powered Research Network, led by Peter A. Merkel, MD, MPH, Professor of Medicine and Epidemiology at the University of Pennsylvania and George Casey, MBA, Vice President of the Vasculitis Foundation, has been approved to receive a three-year $1.4 million award by the Patient-Centered Outcomes Research Institute as part of the second phase of the National Patient-Centered Clinical Research Network.
› Verified 1 days ago
| Home Health Aides | 9.5 |
| Counselors | 3.25 |
| Licensed Practical or Vocational Nurses | 0.25 |
| Medical Social Workers | 2.5 |
| Physicians | 1 |
| Registered Nurses | 10 |
| Other Personnel | 6 |
| Total Employees | 32.5 |
|---|
News Archive
As the cost of sequencing a single human genome drops rapidly, with one company predicting a price of $100 per person in five years, soon the only reason not to look at your "personal genome" will be fear of what bad news lies in your genes.
Nanoparticles are everywhere. From cosmetics and clothes, to soda and snacks. But as versatile as they are, nanoparticles also have a downside, say researchers at Binghamton University and Cornell University in a recent paper published in the journal Nature Nanotechnology. These tiny particles, even in low doses, could have a big impact on our long-term health.
Annually changing flu vaccines with their hit-and-miss effectiveness may soon give way to a single, near-universal flu vaccine, according to a new report from scientists at The Scripps Research Institute and the Dutch biopharmaceutical company Crucell. They describe an antibody that, in animal tests, can prevent or cure infections with a broad variety of influenza viruses, including seasonal and potentially pandemic strains.
CRISPR, a system of genes that bacteria use to defend themselves against viruses, has been found to be involved in helping some bacteria evade the mammalian immune system.
The Vasculitis Patient-Powered Research Network, led by Peter A. Merkel, MD, MPH, Professor of Medicine and Epidemiology at the University of Pennsylvania and George Casey, MBA, Vice President of the Vasculitis Foundation, has been approved to receive a three-year $1.4 million award by the Patient-Centered Outcomes Research Institute as part of the second phase of the National Patient-Centered Clinical Research Network.
› Verified 1 days ago
| Others | 8 |
| Total Volunteers | 8 |
|---|
News Archive
As the cost of sequencing a single human genome drops rapidly, with one company predicting a price of $100 per person in five years, soon the only reason not to look at your "personal genome" will be fear of what bad news lies in your genes.
Nanoparticles are everywhere. From cosmetics and clothes, to soda and snacks. But as versatile as they are, nanoparticles also have a downside, say researchers at Binghamton University and Cornell University in a recent paper published in the journal Nature Nanotechnology. These tiny particles, even in low doses, could have a big impact on our long-term health.
Annually changing flu vaccines with their hit-and-miss effectiveness may soon give way to a single, near-universal flu vaccine, according to a new report from scientists at The Scripps Research Institute and the Dutch biopharmaceutical company Crucell. They describe an antibody that, in animal tests, can prevent or cure infections with a broad variety of influenza viruses, including seasonal and potentially pandemic strains.
CRISPR, a system of genes that bacteria use to defend themselves against viruses, has been found to be involved in helping some bacteria evade the mammalian immune system.
The Vasculitis Patient-Powered Research Network, led by Peter A. Merkel, MD, MPH, Professor of Medicine and Epidemiology at the University of Pennsylvania and George Casey, MBA, Vice President of the Vasculitis Foundation, has been approved to receive a three-year $1.4 million award by the Patient-Centered Outcomes Research Institute as part of the second phase of the National Patient-Centered Clinical Research Network.
› Verified 1 days ago
| Pruitthealth Hospice-swainsboro Location: 667 S Main Street, Swainsboro, Georgia, 30401 Phone: (478) 237-7798 |